Regression of tumor growth in mice upon α1(IV)NC1 treatment is associated with reduced tumor vasculature and increased TUNEL positive endothelial and tumor cells when compared to control tumors, indicating in-vitro activation of caspase-3. Here, CASP3 is linked to neoplasm.